Global Quetiapine Fumarate Market Growth 2020-2025
According to this study, over the next five years the Quetiapine Fumarate market will register a -2.3%% CAGR in terms of revenue, the global market size will reach $ 149.2 million by 2025, from $ 163.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Quetiapine Fumarate business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Quetiapine Fumarate market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Quetiapine Fumarate, covering the supply chain analysis, impact assessment to the Quetiapine Fumarate market size growth rate in several scenarios, and the measures to be undertaken by Quetiapine Fumarate companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Immediate Release Tablets
Extended Release Tablets
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Adult
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
SuZhou NO.4 Phamaceutical Factory
Intas
Accord
Hexal
TAPI
Sun Pharmaceutical
Dr.Reddy's
Hunan Dongting Pharm
Lupin
Fuan Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Supor Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Quetiapine Fumarate consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Quetiapine Fumarate market by identifying its various subsegments.
Focuses on the key global Quetiapine Fumarate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Quetiapine Fumarate with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Quetiapine Fumarate submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Quetiapine Fumarate Consumption 2015-2025
2.1.2 Quetiapine Fumarate Consumption CAGR by Region
2.2 Quetiapine Fumarate Segment by Type
2.2.1 Immediate Release Tablets
2.2.2 Extended Release Tablets
2.3 Quetiapine Fumarate Consumption by Type
2.3.1 Global Quetiapine Fumarate Consumption Market Share by Type (2015-2020)
2.3.2 Global Quetiapine Fumarate Revenue and Market Share by Type (2015-2020)
2.3.3 Global Quetiapine Fumarate Sale Price by Type (2015-2020)
2.4 Quetiapine Fumarate Segment by Application
2.4.1 Adult
2.4.2 Others
2.5 Quetiapine Fumarate Consumption by Application
2.5.1 Global Quetiapine Fumarate Consumption Market Share by Type (2015-2020)
2.5.2 Global Quetiapine Fumarate Value and Market Share by Type (2015-2020)
2.5.3 Global Quetiapine Fumarate Sale Price by Type (2015-2020)
3 Global Quetiapine Fumarate by Company
3.1 Global Quetiapine Fumarate Sales Market Share by Company
3.1.1 Global Quetiapine Fumarate Sales by Company (2018-2020)
3.1.2 Global Quetiapine Fumarate Sales Market Share by Company (2018-2020)
3.2 Global Quetiapine Fumarate Revenue Market Share by Company
3.2.1 Global Quetiapine Fumarate Revenue by Company (2018-2020)
3.2.2 Global Quetiapine Fumarate Revenue Market Share by Company (2018-2020)
3.3 Global Quetiapine Fumarate Sale Price by Company
3.4 Global Quetiapine Fumarate Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Quetiapine Fumarate Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Quetiapine Fumarate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Quetiapine Fumarate by Regions
4.1 Quetiapine Fumarate by Regions
4.2 Americas Quetiapine Fumarate Consumption Growth
4.3 APAC Quetiapine Fumarate Consumption Growth
4.4 Europe Quetiapine Fumarate Consumption Growth
4.5 Middle East & Africa Quetiapine Fumarate Consumption Growth
5 Americas
5.1 Americas Quetiapine Fumarate Consumption by Countries
5.1.1 Americas Quetiapine Fumarate Consumption by Countries (2015-2020)
5.1.2 Americas Quetiapine Fumarate Value by Countries (2015-2020)
5.2 Americas Quetiapine Fumarate Consumption by Type
5.3 Americas Quetiapine Fumarate Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Quetiapine Fumarate Consumption by Regions
6.1.1 APAC Quetiapine Fumarate Consumption by Regions (2015-2020)
6.1.2 APAC Quetiapine Fumarate Value by Regions (2015-2020)
6.2 APAC Quetiapine Fumarate Consumption by Type
6.3 APAC Quetiapine Fumarate Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Quetiapine Fumarate by Countries
7.1.1 Europe Quetiapine Fumarate Consumption by Countries (2015-2020)
7.1.2 Europe Quetiapine Fumarate Value by Countries (2015-2020)
7.2 Europe Quetiapine Fumarate Consumption by Type
7.3 Europe Quetiapine Fumarate Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Quetiapine Fumarate by Countries
8.1.1 Middle East & Africa Quetiapine Fumarate Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Quetiapine Fumarate Value by Countries (2015-2020)
8.2 Middle East & Africa Quetiapine Fumarate Consumption by Type
8.3 Middle East & Africa Quetiapine Fumarate Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Quetiapine Fumarate Distributors
10.3 Quetiapine Fumarate Customer
11 Global Quetiapine Fumarate Market Forecast
11.1 Global Quetiapine Fumarate Consumption Forecast (2021-2025)
11.2 Global Quetiapine Fumarate Forecast by Regions
11.2.1 Global Quetiapine Fumarate Forecast by Regions (2021-2025)
11.2.2 Global Quetiapine Fumarate Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Quetiapine Fumarate Forecast by Type
11.8 Global Quetiapine Fumarate Forecast by Application
12 Key Players Analysis
12.1 AstraZeneca
12.1.1 Company Information
12.1.2 Quetiapine Fumarate Product Offered
12.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 SuZhou NO.4 Phamaceutical Factory
12.2.1 Company Information
12.2.2 Quetiapine Fumarate Product Offered
12.2.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 SuZhou NO.4 Phamaceutical Factory Latest Developments
12.3 Intas
12.3.1 Company Information
12.3.2 Quetiapine Fumarate Product Offered
12.3.3 Intas Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Intas Latest Developments
12.4 Accord
12.4.1 Company Information
12.4.2 Quetiapine Fumarate Product Offered
12.4.3 Accord Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Accord Latest Developments
12.5 Hexal
12.5.1 Company Information
12.5.2 Quetiapine Fumarate Product Offered
12.5.3 Hexal Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Hexal Latest Developments
12.6 TAPI
12.6.1 Company Information
12.6.2 Quetiapine Fumarate Product Offered
12.6.3 TAPI Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 TAPI Latest Developments
12.7 Sun Pharmaceutical
12.7.1 Company Information
12.7.2 Quetiapine Fumarate Product Offered
12.7.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Sun Pharmaceutical Latest Developments
12.8 Dr.Reddy's
12.8.1 Company Information
12.8.2 Quetiapine Fumarate Product Offered
12.8.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Dr.Reddy's Latest Developments
12.9 Hunan Dongting Pharm
12.9.1 Company Information
12.9.2 Quetiapine Fumarate Product Offered
12.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Hunan Dongting Pharm Latest Developments
12.10 Lupin
12.10.1 Company Information
12.10.2 Quetiapine Fumarate Product Offered
12.10.3 Lupin Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Lupin Latest Developments
12.11 Fuan Pharmaceutical
12.11.1 Company Information
12.11.2 Quetiapine Fumarate Product Offered
12.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Fuan Pharmaceutical Latest Developments
12.12 Zhejiang Huahai Pharmaceutical
12.12.1 Company Information
12.12.2 Quetiapine Fumarate Product Offered
12.12.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Zhejiang Huahai Pharmaceutical Latest Developments
12.13 Zhejiang Supor Pharmaceuticals
12.13.1 Company Information
12.13.2 Quetiapine Fumarate Product Offered
12.13.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Zhejiang Supor Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Quetiapine Fumarate Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Immediate Release Tablets
Table 5. Major Players of Extended Release Tablets
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Quetiapine Fumarate Consumption Market Share by Type (2015-2020)
Table 8. Global Quetiapine Fumarate Revenue by Type (2015-2020) ($ million)
Table 9. Global Quetiapine Fumarate Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Quetiapine Fumarate Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Quetiapine Fumarate Consumption Market Share by Application (2015-2020)
Table 13. Global Quetiapine Fumarate Value by Application (2015-2020)
Table 14. Global Quetiapine Fumarate Value Market Share by Application (2015-2020)
Table 15. Global Quetiapine Fumarate Sale Price by Application (2015-2020)
Table 16. Global Quetiapine Fumarate Sales by Company (2017-2019) (MT)
Table 17. Global Quetiapine Fumarate Sales Market Share by Company (2017-2019)
Table 18. Global Quetiapine Fumarate Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Quetiapine Fumarate Revenue Market Share by Company (2017-2019)
Table 20. Global Quetiapine Fumarate Sale Price by Company (2017-2019)
Table 21. Global Quetiapine Fumarate Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Quetiapine Fumarate Products Offered
Table 23. Quetiapine Fumarate Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Quetiapine Fumarate Consumption by Regions 2015-2020 (MT)
Table 25. Global Quetiapine Fumarate Consumption Market Share by Regions 2015-2020
Table 26. Global Quetiapine Fumarate Value by Regions 2015-2020 ($ Millions)
Table 27. Global Quetiapine Fumarate Value Market Share by Regions 2015-2020
Table 28. Americas Quetiapine Fumarate Consumption by Countries (2015-2020) (MT)
Table 29. Americas Quetiapine Fumarate Consumption Market Share by Countries (2015-2020)
Table 30. Americas Quetiapine Fumarate Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Quetiapine Fumarate Value Market Share by Countries (2015-2020)
Table 32. Americas Quetiapine Fumarate Consumption by Type (2015-2020) (MT)
Table 33. Americas Quetiapine Fumarate Consumption Market Share by Type (2015-2020)
Table 34. Americas Quetiapine Fumarate Consumption by Application (2015-2020) (MT)
Table 35. Americas Quetiapine Fumarate Consumption Market Share by Application (2015-2020)
Table 36. APAC Quetiapine Fumarate Consumption by Countries (2015-2020) (MT)
Table 37. APAC Quetiapine Fumarate Consumption Market Share by Countries (2015-2020)
Table 38. APAC Quetiapine Fumarate Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Quetiapine Fumarate Value Market Share by Regions (2015-2020)
Table 40. APAC Quetiapine Fumarate Consumption by Type (2015-2020) (MT)
Table 41. APAC Quetiapine Fumarate Consumption Market Share by Type (2015-2020)
Table 42. APAC Quetiapine Fumarate Consumption by Application (2015-2020) (MT)
Table 43. APAC Quetiapine Fumarate Consumption Market Share by Application (2015-2020)
Table 44. Europe Quetiapine Fumarate Consumption by Countries (2015-2020) (MT)
Table 45. Europe Quetiapine Fumarate Consumption Market Share by Countries (2015-2020)
Table 46. Europe Quetiapine Fumarate Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Quetiapine Fumarate Value Market Share by Countries (2015-2020)
Table 48. Europe Quetiapine Fumarate Consumption by Type (2015-2020) (MT)
Table 49. Europe Quetiapine Fumarate Consumption Market Share by Type (2015-2020)
Table 50. Europe Quetiapine Fumarate Consumption by Application (2015-2020) (MT)
Table 51. Europe Quetiapine Fumarate Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Quetiapine Fumarate Consumption by Countries (2015-2020) (MT)
Table 53. Middle East & Africa Quetiapine Fumarate Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Quetiapine Fumarate Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Quetiapine Fumarate Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Quetiapine Fumarate Consumption by Type (2015-2020) (MT)
Table 57. Middle East & Africa Quetiapine Fumarate Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Quetiapine Fumarate Consumption by Application (2015-2020) (MT)
Table 59. Middle East & Africa Quetiapine Fumarate Consumption Market Share by Application (2015-2020)
Table 60. Quetiapine Fumarate Distributors List
Table 61. Quetiapine Fumarate Customer List
Table 62. Global Quetiapine Fumarate Consumption Forecast by Countries (2021-2025) (MT)
Table 63. Global Quetiapine Fumarate Consumption Market Forecast by Regions
Table 64. Global Quetiapine Fumarate Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Quetiapine Fumarate Value Market Share Forecast by Regions
Table 66. Global Quetiapine Fumarate Consumption Forecast by Type (2021-2025) (MT)
Table 67. Global Quetiapine Fumarate Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Quetiapine Fumarate Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Quetiapine Fumarate Value Market Share Forecast by Type (2021-2025)
Table 70. Global Quetiapine Fumarate Consumption Forecast by Application (2021-2025) (MT)
Table 71. Global Quetiapine Fumarate Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Quetiapine Fumarate Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Quetiapine Fumarate Value Market Share Forecast by Application (2021-2025)
Table 74. AstraZeneca Product Offered
Table 75. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. AstraZeneca Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 79. SuZhou NO.4 Phamaceutical Factory Product Offered
Table 80. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. SuZhou NO.4 Phamaceutical Factory Main Business
Table 82. SuZhou NO.4 Phamaceutical Factory Latest Developments
Table 83. SuZhou NO.4 Phamaceutical Factory Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 84. Intas Product Offered
Table 85. Intas Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Intas Main Business
Table 87. Intas Latest Developments
Table 88. Intas Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 89. Accord Product Offered
Table 90. Accord Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Accord Main Business
Table 92. Accord Latest Developments
Table 93. Accord Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 94. Hexal Product Offered
Table 95. Hexal Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 96. Hexal Main Business
Table 97. Hexal Latest Developments
Table 98. Hexal Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 99. TAPI Product Offered
Table 100. TAPI Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 101. TAPI Main Business
Table 102. TAPI Latest Developments
Table 103. TAPI Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 104. Sun Pharmaceutical Product Offered
Table 105. Sun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 106. Sun Pharmaceutical Main Business
Table 107. Sun Pharmaceutical Latest Developments
Table 108. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 109. Dr.Reddy's Product Offered
Table 110. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Dr.Reddy's Main Business
Table 112. Dr.Reddy's Latest Developments
Table 113. Dr.Reddy's Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 114. Hunan Dongting Pharm Product Offered
Table 115. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 116. Hunan Dongting Pharm Main Business
Table 117. Hunan Dongting Pharm Latest Developments
Table 118. Hunan Dongting Pharm Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 119. Lupin Product Offered
Table 120. Lupin Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 121. Lupin Main Business
Table 122. Lupin Latest Developments
Table 123. Lupin Basic Information, Company Total Revenue (in $ million), Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 124. Fuan Pharmaceutical Product Offered
Table 125. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 126. Fuan Pharmaceutical Main Business
Table 127. Fuan Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Fuan Pharmaceutical Latest Developments
Table 129. Zhejiang Huahai Pharmaceutical Product Offered
Table 130. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 131. Zhejiang Huahai Pharmaceutical Main Business
Table 132. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Zhejiang Huahai Pharmaceutical Latest Developments
Table 134. Zhejiang Supor Pharmaceuticals Product Offered
Table 135. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 136. Zhejiang Supor Pharmaceuticals Main Business
Table 137. Zhejiang Supor Pharmaceuticals Latest Developments
Table 138. Zhejiang Supor Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Quetiapine Fumarate
Figure 2. Quetiapine Fumarate Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Quetiapine Fumarate Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Quetiapine Fumarate Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Immediate Release Tablets
Figure 7. Product Picture of Extended Release Tablets
Figure 8. Global Quetiapine Fumarate Consumption Market Share by Type (2015-2020)
Figure 9. Global Quetiapine Fumarate Value Market Share by Type (2015-2020)
Figure 10. Quetiapine Fumarate Consumed in Adult
Figure 11. Global Quetiapine Fumarate Market: Adult (2015-2020) (MT)
Figure 12. Global Quetiapine Fumarate Market: Adult (2015-2020) ($ Millions)
Figure 13. Quetiapine Fumarate Consumed in Others
Figure 14. Global Quetiapine Fumarate Market: Others (2015-2020) (MT)
Figure 15. Global Quetiapine Fumarate Market: Others (2015-2020) ($ Millions)
Figure 16. Global Quetiapine Fumarate Consumption Market Share by Application (2015-2020)
Figure 17. Global Quetiapine Fumarate Value Market Share by Application (2015-2020)
Figure 18. Global Quetiapine Fumarate Sales Market Share by Company in 2017
Figure 19. Global Quetiapine Fumarate Sales Market Share by Company in 2019
Figure 20. Global Quetiapine Fumarate Revenue Market Share by Company in 2017
Figure 21. Global Quetiapine Fumarate Revenue Market Share by Company in 2019
Figure 22. Global Quetiapine Fumarate Sale Price by Company in 2019
Figure 23. Global Quetiapine Fumarate Consumption Market Share by Regions 2015-2020
Figure 24. Global Quetiapine Fumarate Value Market Share by Regions 2015-2020
Figure 25. Americas Quetiapine Fumarate Consumption 2015-2020 (MT)
Figure 26. Americas Quetiapine Fumarate Value 2015-2020 ($ Millions)
Figure 27. APAC Quetiapine Fumarate Consumption 2015-2020 (MT)
Figure 28. APAC Quetiapine Fumarate Value 2015-2020 ($ Millions)
Figure 29. Europe Quetiapine Fumarate Consumption 2015-2020 (MT)
Figure 30. Europe Quetiapine Fumarate Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Quetiapine Fumarate Consumption 2015-2020 (MT)
Figure 32. Middle East & Africa Quetiapine Fumarate Value 2015-2020 ($ Millions)
Figure 33. Americas Quetiapine Fumarate Consumption Market Share by Countries in 2019
Figure 34. Americas Quetiapine Fumarate Value Market Share by Countries in 2019
Figure 35. Americas Quetiapine Fumarate Consumption Market Share by Type in 2019
Figure 36. Americas Quetiapine Fumarate Consumption Market Share by Application in 2019
Figure 37. United States Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 38. United States Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 40. Canada Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 42. Mexico Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Quetiapine Fumarate Consumption Market Share by Countries in 2019
Figure 44. APAC Quetiapine Fumarate Value Market Share by Regions in 2019
Figure 45. APAC Quetiapine Fumarate Consumption Market Share by Type in 2019
Figure 46. APAC Quetiapine Fumarate Consumption Market Share by Application in 2019
Figure 47. China Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 48. China Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 50. Japan Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 52. Korea Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 54. Southeast Asia Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 55. India Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 56. India Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 58. Australia Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Quetiapine Fumarate Consumption Market Share by Countries in 2019
Figure 60. Europe Quetiapine Fumarate Value Market Share by Countries in 2019
Figure 61. Europe Quetiapine Fumarate Consumption Market Share by Type in 2019
Figure 62. Europe Quetiapine Fumarate Consumption Market Share by Application in 2019
Figure 63. Germany Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 64. Germany Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 65. France Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 66. France Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 67. UK Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 68. UK Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 70. Italy Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 72. Russia Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Quetiapine Fumarate Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Quetiapine Fumarate Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Quetiapine Fumarate Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Quetiapine Fumarate Consumption Market Share by Application in 2019
Figure 77. Egypt Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 78. Egypt Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 80. South Africa Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 82. Israel Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 84. Turkey Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Quetiapine Fumarate Consumption Growth 2015-2020 (MT)
Figure 86. GCC Countries Quetiapine Fumarate Value Growth 2015-2020 ($ Millions)
Figure 87. Global Quetiapine Fumarate Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 88. Global Quetiapine Fumarate Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 90. Americas Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 91. APAC Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 92. APAC Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 93. Europe Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 94. Europe Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 96. Middle East & Africa Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 97. United States Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 98. United States Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 99. Canada Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 100. Canada Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 101. Mexico Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 102. Mexico Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 103. Brazil Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 104. Brazil Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 105. China Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 106. China Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 107. Japan Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 108. Japan Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 109. Korea Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 110. Korea Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 112. Southeast Asia Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 113. India Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 114. India Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 115. Australia Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 116. Australia Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 117. Germany Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 118. Germany Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 119. France Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 120. France Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 121. UK Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 122. UK Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 123. Italy Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 124. Italy Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 125. Russia Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 126. Russia Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 127. Spain Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 128. Spain Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 129. Egypt Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 130. Egypt Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 131. South Africa Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 132. South Africa Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 133. Israel Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 134. Israel Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 135. Turkey Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 136. Turkey Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Quetiapine Fumarate Consumption 2021-2025 (MT)
Figure 138. GCC Countries Quetiapine Fumarate Value 2021-2025 ($ Millions)
Figure 139. AstraZeneca Quetiapine Fumarate Market Share (2018-2020)
Figure 140. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Market Share (2018-2020)
Figure 141. Intas Quetiapine Fumarate Market Share (2018-2020)
Figure 142. Accord Quetiapine Fumarate Market Share (2018-2020)
Figure 143. Hexal Quetiapine Fumarate Market Share (2018-2020)
Figure 144. TAPI Quetiapine Fumarate Market Share (2018-2020)
Figure 145. Sun Pharmaceutical Quetiapine Fumarate Market Share (2018-2020)
Figure 146. Dr.Reddy's Quetiapine Fumarate Market Share (2018-2020)
Figure 147. Hunan Dongting Pharm Quetiapine Fumarate Market Share (2018-2020)
Figure 148. Lupin Quetiapine Fumarate Market Share (2018-2020)
Figure 149. Fuan Pharmaceutical Quetiapine Fumarate Market Share (2018-2020)
Figure 150. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Market Share (2018-2020)
Figure 151. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets